← Leaderboards
Miriam Sargon Udler
Massachusetts General Hospital
$2,215,902
Attributed
$3,702,961
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.3M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,366,961 · 5
By mechanism
U54$7,664,000 · 1
U01$1,568,954 · 1
K23$999,827 · 1
R01$882,180 · 1
R03$252,000 · 1
Top collaborators
- Josep Maria Mercader5 shared
- Louis H. Philipson4 shared
- Kristina Marie Utzschneider2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Jose Carlos Florez$39,251,920
- Hailiang Huang$11,321,434
- Arthur Y Kim$8,139,557
- Raymond T Chung$38,306,004
- Jeremiah M Scharf$8,914,691
Others in their field
Other Emerging Leaders on “Diabetes Mellitus”
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Bradley G Hammill · Duke University$15,773,864
- Francisco S Sy · University Of Nevada Las Vegas$11,999,607
- Gary Fanger · Rise Therapeutics, Llc$11,687,853
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$11,320,710
Research focus
Diabetes MellitusPhenotypeGenetic VariantGeneticVariantCohortGenesNon-Insulin-Dependent Diabetes MellitusTraitPatient CareFunctional DisorderPrecision MedicineData SetGenetic VariationBiobankLinkGenetic RiskEtiologyGenome Wide Association StudyPathway InteractionsClassificationGenomicsParticipantDiagnosis
Grant awards (16)
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2025 · DK
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$785,491
R01 · FY2025 · DK
GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes in Diverse Populations (GEMS-T2D)$784,318
U01 · FY2025 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$164,000
U54 · FY2025 · DK
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$64,289
R01 · FY2025 · DK
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$32,400
R01 · FY2025 · DK
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2024 · DK
GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes in Diverse Populations (GEMS-T2D)$784,636
U01 · FY2024 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus$2,500,000
U54 · FY2023 · DK
Extension of Type 2 Diabetes Genetic Clustering to Populations of non-European Ancestry$126,000
R03 · FY2023 · DK · contact PI
Extension of Type 2 Diabetes Genetic Clustering to Populations of non-European Ancestry$126,000
R03 · FY2022 · DK · contact PI
Clinical Implications of Genetically Defined Diabetes Subtypes and Application to Electronic Health Medical Record Systems$200,880
K23 · FY2021 · DK · contact PI
Clinical Implications of Genetically Defined Diabetes Subtypes and Application to Electronic Health Medical Record Systems$200,880
K23 · FY2020 · DK · contact PI
Clinical Implications of Genetically Defined Diabetes Subtypes and Application to Electronic Health Medical Record Systems$198,095
K23 · FY2019 · DK · contact PI
Clinical Implications of Genetically Defined Diabetes Subtypes and Application to Electronic Health Medical Record Systems$199,532
K23 · FY2018 · DK · contact PI
Clinical Implications of Genetically Defined Diabetes Subtypes and Application to Electronic Health Medical Record Systems$200,440
K23 · FY2017 · DK · contact PI